Maraviroc for long COVID. This article goes into lots more detail about viral persistence and other possible causes for long COVID. (My own opinion is that, as they say, there are several possible reasons for long COVID, and that all or most of them cause the problem, but will need different treatments)

Quote:

---

In a feasibility study, Putrino's lab will study two repurposed HIV antivirals, emtricitabine/tenofovir (Truvada) and maraviroc. "Maraviroc has had some early published evidence that it does have some antiviral action on SARS-CoV-2 in the body," he noted. "Truvada also has some weaker evidence showing it has action on SARS-CoV-2, but more importantly, it has strong evidence that it can act quite aggressively on persistent EBV," which may be a factor in a subset of long COVIDopens in a new tab or window patients.
https://www.medpagetoday.com/neurology/longco...ate_active

---